Aerocrine/Stallergenes sign exclusive NiOx Mino distribution pact
Aerocrine and Stallergenes have signed an exclusive long-term distribution agreement for Aerocrine's airway inflammation monitor and test kit. The agreement will initially cover France, Italy, Poland, Turkey and the Middle East and could be extended to additional countries.
The agreement, which comes into effect on 1st September 2012, gives Stallergenes exclusive rights for the marketing, sales and distribution of Aerocrine's instrument NiOx Mino and test kits, used for diagnosing and monitoring patients with asthma. The existing distribution agreement of Aerocrine with Thermo Fisher Scientific/Phadia, which covers France and Italy, will be terminated on the effective date of this new agreement.